Clinical trials
Observational Ischemic Stroke trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Recruiting | 16 |
| Unknown status | 7 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Montpellier | 8 |
| Assistance Publique - Hôpitaux de Paris | 5 |
| Fondation Ophtalmologique Adolphe de Rothschild | 5 |
| Hospices Civils de Lyon | 5 |
| Centre Hospitalier Universitaire Dijon | 3 |
| Biotronik SE & Co. KG | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| Penumbra Inc. | 2 |
| Stryker Neurovascular | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemic Stroke | 55 |
| Stroke | 15 |
| Cerebral Hemorrhage | 3 |
| Cerebrovascular Disorders | 3 |
| Atrial Fibrillation | 2 |
| Brain Ischemia | 2 |
| Cardiovascular Diseases | 2 |
| Carotid Stenosis | 2 |
| Intracranial Aneurysm | 2 |
| Ischemic Attack, Transient | 2 |
Trials
Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.